Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2023-08-09 | Iconovo | KALLELSE TILL EXTRA BOLAGSSTÄMMA I ICONOVO AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-17 | Penser Access | Penser Access: Q2 2023 - Iconovo | Pressreleaser | Visa Stäng |
|
||||
2023-07-14 | Penser Access | Penser Access: Intervju med Iconovo - Erik Penser Bank - 14 juli 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-07-14 | Iconovo | KVARTALSRAPPORT, Q2 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-07-13 | Iconovo | Iconovo ökar försäljningsinsatserna och säkrar produktionen för ICOcap genom omstrukturerat avtal med Stevanato | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-13 | Iconovo | Iconovo increases sales efforts and supply chain security for ICOcap through restructured agreement with Stevanato | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Iconovo increases sales efforts and supply chain security for ICOcap through restructured agreement with StevanatoIconovo AB (publ), which develops complete inhalation products for a global market, announces that it has regained the global rights to sell and distribute ICOcap® inhalers from Stevanato Group. Iconovo now aims to increase sales efforts pertaining to ICOcap®, and Stevanato Group will serve as the sole manufacturing partner. In conjunction with restructuring the agreement, Iconovo will receive a payment of EUR 200,000 during the third quarter to be used for the application for CE certification of ICOcap. The amended collaboration structure is expected to increase the company’s future profit margin on products sold. The new collaboration structure with Stevanato Group is part of Iconovo’s strategy to establish an attractive end-to-end offer with contract development and formulation services, as well as direct sales of inhalers to end customers. ”Iconovo has evolved greatly in the last few years. We receive a lot of interest in ICOcap from companies developing original medicines and we have all the resources needed for contract development in our own labs. With our broad customer base, formulation expertise, and established infrastructure we are now much better positioned to manage the sales and marketing of ICOcap, making this a natural step forward for Iconovo” comments Johan Wäborg, CEO at Iconovo. As part of the amended agreement, Iconovo will receive a payment of EUR 200,000 which will be used for an application for CE certification according to MDR (Medical Device Regulation), slated for late 2023/early 2024. In connection with this, Iconovo will adapt its medical device quality management system for the manufacturing and sales of medical devices. ICOcap® is an inhaler for medicines in capsules that are loaded one at a time. It has a robust, unique grip-friendly design, a patented integrated lid, and low inhalation resistance. ICOcap® is available in two versions, with the same function and performance as the established inhalers Breezhaler® from Novartis and RS01 from RPC. A standardized version of ICOcap® is available off-the-shelf, and the inhaler can also be optimized to provide maximum product performance for a given drug substance. |
||||
2023-06-22 | Iconovo | BioStock: Iconovo ingår samarbete med Affilogic | Pressreleaser | Visa Stäng |
|
||||
2023-06-22 | Iconovo | BioStock: Iconovo initiates collaboration with Affilogic | Pressreleaser | Visa Stäng |
|
||||
2023-06-19 | Iconovo | Iconovo inleder feasibility-studie med Affilogic för utveckling av inhalerbara Nanofitin®-baserade bioterapier | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-19 | Iconovo | Iconovo initiates feasibility study with Affilogic for development of inhalable Nanofitin®-based biotherapies | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-15 | Iconovo | BioStock: Iconovo lanserar Accelerator Program | Pressreleaser | Visa Stäng |
|
||||
2023-06-15 | Iconovo | BioStock: Iconovo launch Accelerator Program | Pressreleaser | Visa Stäng |
|
||||
2023-06-09 | Iconovo | Iconovo inleder samarbete med danskt mindre bolag om utveckling av en ny inhalerbar behandling mot sällsynt sjukdom | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-09 | Iconovo | Iconovo initiates collaboration with a small Danish company to develop a new inhalable treatment for a rare disease | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-01 | Iconovo | Iconovo ökar möjligheterna för kunder inom affärsområdet originalläkemedel att finansiera innovativa utvecklingsprojekt | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-01 | Iconovo | Iconovo provides increased opportunities for customers in its Novel Pharmaceuticals business segment to finance innovative development projects | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-26 | Iconovo | Kommuniké från årsstämma i Iconovo AB den 22 maj 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-26 | Iconovo | BioStock: Iconovo inleder strukturerad säljprocess för ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-05-26 | Iconovo | BioStock: Iconovo initiates structured sales process for ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-05-23 | Iconovo | Carl Lindgren new board member of Iconovo | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-23 | Iconovo | Carl Lindgren ny styrelseledamot i Iconovo | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-22 | Iconovo | Iconovo initiates structured process for out-licensing of ICOpre with a global investment bank | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-22 | Iconovo | Iconovo inleder strukturerad process för utlicensiering av ICOpre i samarbete med global investmentbank | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-15 | Iconovo | BioStock: Iconovo's oxytocin treatment in clinical phase I study | Pressreleaser | Visa Stäng |
|
||||
2023-05-15 | Iconovo | BioStock: Iconovos oxytocinbehandling i klinisk fas I-studie | Pressreleaser | Visa Stäng |
|
||||
2023-05-11 | Iconovo | Iconovo’s partner Monash University has initiated a phase I clinical trial on inhaled oxytocin in ICOone® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-11 | Iconovo | Iconovos partner, Monash University har inlett en klinisk fas I-studie av inhalerat oxytocin i ICOone® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-02 | Penser Access | Penser Access: Avtal för ICOone - Iconovo | Pressreleaser | Visa Stäng |
|
||||
2023-05-02 | Penser Access | Penser Access: Intervju med Iconovo - Erik Penser Bank - 2 maj 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-04-28 | Iconovo | Rättelse: DELÅRSRAPPORT JANUARI - MARS 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-28 | Iconovo | Genomförd riktad emission på 55 MSEK stärker bolaget | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-28 | Iconovo | ICONOVO AB PUBLICERAR ÅRSREDOVISNING FÖR 2022 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-04-20 | Iconovo | Kallelse till årsstämma i Iconovo AB | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-14 | Iconovo | Iconovo erhåller nytt patent i Japan för sin inhalatorplattform ICOone® | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-14 | Iconovo | Iconovo receives new patent in Japan for its ICOone® inhaler platform | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-04 | Iconovo | BioStock: Arcede Pharma och Iconovo erhåller finansiering från Swelife | Pressreleaser | Visa Stäng |
|
||||
2023-04-04 | Iconovo | BioStock: Arcede Pharma and Iconovo receive funding from Swelife | Pressreleaser | Visa Stäng |
|
||||
2023-04-04 | Iconovo | Iconovo to evaluate ICOone Nasal for the development of antiviral nasal inhalation product | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-04-04 | Iconovo | Iconovo utvärderar ICOone Nasal för utveckling av antiviral nasal inhalationsprodukt | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-31 | Iconovo | Iconovo, Arcede Pharma AB och Lunds universitet erhåller finansiering från Swelife för utveckling av en ny behandling mot KOL och svår astma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-03-16 | Iconovo | Iconovo Pharma har beviljats partihandelstillstånd av Läkemedelsverket | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-15 | Penser Access | Penser Access: Inhalationsplattformarna klara - Iconovo | Pressreleaser | Visa Stäng |
|
||||
2023-02-14 | Iconovo | BioStock: Iconovo carries out directed share issue for continued value creation | Pressreleaser | Visa Stäng |
|
||||
2023-02-14 | Iconovo | BioStock: Iconovo genomför riktad emission för fortsatt värdeskapande | Pressreleaser | Visa Stäng |
|
||||
2023-02-10 | Iconovo | Iconovos vd förvärvar aktier för 500 000 SEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-09 | Iconovo | Iconovos styrelseledamot och största ägare förvärvar aktier för 3 000 000 SEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB has completed a directed new share issue of SEK 55 million | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB har genomfört en riktad nyemission om 55 miljoner SEK | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | BOKSLUTSKOMMUNIKÉ 1 JANUARI – 31 DECEMBER 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | YEAR-END REPORT JANUARY-DECEMBER 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB evaluates the conditions to carry out a directed new share issue of approximately SEK 50 million and brings forward publication of the year-end report for the financial year 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-08 | Iconovo | Iconovo AB utreder förutsättningarna för att genomföra en riktad nyemission om cirka 50 miljoner SEK och tidigarelägger offentliggörande av bokslutskommunikén avseende räkenskapsåret 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-02-03 | Iconovo | Iconovo announces positive results in interim report from project with ICOone Nasal® | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-02-03 | Iconovo | Iconovo meddelar positiva resultat i interimsrapport från projekt med ICOone Nasal® | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-26 | Iconovo | Iconovo erhåller nytt europeiskt patent för sin engångsinhalator ICOone | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-26 | Iconovo | Iconovo receives approval of new European patent for its single-use inhaler ICOone® | Analyser | Ladda ner | Visa Stäng |
|
||||
2023-01-17 | Iconovo | BioStock: Iconovo starts 2023 with negotiations for ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-01-17 | Iconovo | BioStock: Iconovo inleder 2023 med förhandlingar för ICOpre | Pressreleaser | Visa Stäng |
|
||||
2023-01-11 | Iconovo | Iconovo har inlett förhandlingar med ett globalt läkemedelsföretag om ett potentiellt licensavtal för sin inhalator ICOpre® | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-15 | Iconovo | Iconovo utser Henrik Damkjær Simonsen till Chief Financial Officer | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-15 | Iconovo | Iconovo appoints Henrik Damkjær Simonsen as Chief Financial Officer | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-07 | Iconovo | Iconovo's ICOone® inhaler platform receives new patent approval in the US | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-07 | Iconovo | Iconovos inhalatorplattform ICOone® erhåller nytt patentgodkännande i USA | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-12-05 | Iconovo | BioStock: Iconovo satsar på läkemedelsförsäljning i Norden | Pressreleaser | Visa Stäng |
|
||||
2022-12-05 | Iconovo | BioStock: Iconovo establishes Nordic pharmaceutical sales | Pressreleaser | Visa Stäng |
|
||||
2022-11-16 | Iconovo | Iconovo utser Peter Åkerlund till tillförordnad CFO | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-08 | Iconovo | Valberedning utsedd Iconovo | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-08 | Iconovo | Nomination Committee appointed at Iconovo | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-11-08 | Iconovo | BioStock: Iconovo reports Q3 and arranges pandemic event | Pressreleaser | Visa Stäng |
|
||||
2022-11-08 | Iconovo | BioStock: Iconovo rapporterar Q3 och arrangerar pandemievent | Pressreleaser | Visa Stäng |
|
||||
2022-11-04 | Penser Access | Penser Access: Intervju med Iconovo - Erik Penser Bank - 3 nov 2022 | Analyser | Visa Stäng |
|
||||
2022-11-03 | Iconovo | Abbreviated interim report 1 January - 30 September | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-31 | Penser Access | Penser Access: Leverans av nya avtal på väg - Iconovo | Analyser | Visa Stäng |
|
||||
2022-10-28 | Iconovo | DELÅRSRAPPORT 1 JANUARI – 30 SEPTEMBER 2022 | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-24 | Iconovo | BioStock: Founder and CTO on Iconovo's journey | Pressreleaser | Visa Stäng |
|
||||
2022-10-24 | Iconovo | BioStock: Iconovos grundare och CTO om bolagets resa | Pressreleaser | Visa Stäng |
|
||||
2022-10-24 | Iconovo | Iconovos unika engångsinhalator ICOone® Nasal erhöll goda omdömen i användarstudie | Analyser | Ladda ner | Visa Stäng |
|
||||
2022-10-24 | Iconovo | Iconovo's unique single dose inhaler ICOone® Nasal received high marks in user study | Analyser | Ladda ner | Visa Stäng |
|